Sam Ropp - Sep 15, 2023 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Commercial Officer
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/15/2023, 07:03 PM
Previous filing
Aug 17, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +4.19K +99.98% 8.38K Sep 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -4.19K -6.67% 58.6K Sep 15, 2023 Common Stock 4.19K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.